Get started
Author

Piotr Zieminski

Observed names: P. Zieminski, Piotr ZIEMINSKI, Zieminski, Piotr
OpenAlex ID: A5071207541
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
2025 · Francis Couturaud, Jeannot Schmidt, et al. · The Lancet · 118
PDF
Usefulness and safety of a dedicated team to prone patients with severe ARDS due to COVID-19
2020 · Antoine Kimmoun, Bruno Levy, et al. · Critical Care · 20
PDF
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
2023 · Stéphane Zuily, Benjamin Lefèvre, et al. · EClinicalMedicine · 18
PDF
Vascular manifestations and kyphoscoliosis due to a novel mutation of PLOD1 gene
2020 · Piotr Zieminski, Jessie Risse, et al. · Acta cardiologica. Supplementum · 4
Anévrysmes infectieux de l’aorte abdominale. Diagnostic
2021 · D. Wahl, P. Zieminski, et al. · JMV-Journal de Médecine Vasculaire
Anévrysmes infectieux de l’aorte abdominale. Diagnostic
2020 · D. Wahl, P. Zieminski, et al. · JMV-Journal de Médecine Vasculaire
Manifestations vasculaires et syndrome d’Ehlers-Danlos cyphoscoliotique par mutation inédite du gène PLOD1
2018 · Zieminski, Piotr · HAL
Works count: 7
Citation count: 160
H-index: 4
I10-index: 3
Year
Topic
Type